Ares Genetics
Wholly owned subsidiary of Curetis GmbH, a developer of next-generation molecular diagnostic solutions for infectious diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
$6—9m (Dealroom.co estimates Jan 2019.)
Company register number FN 468899 h
Vienna Austria (HQ)
- hard tech
- biotechnology
- horizon europe
- analytics
- core ai
- testing
- ai applications
- eit ecosystem
- genetics
- dna
- eit health
- drug development
- tech for biotech & pharma
- health it
- ai drug discovery
- medical diagnostics
- european health catapult (eit health)
- compbio
- molecular biology
- ivd
- european health catapult 2019 (eit health)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Grant | ||
€1.3m | Seed | ||
| Total Funding | $1.4m | ||
Related Content
Recent News about Ares Genetics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.